Logo Image
|Articles|November 5, 2013

Strengthening the Management of Clinical Trial Supplies

This white paper discusses the benefits of predictive technology to forecast the clinical supply needs of a clinical trial.

RELATED ARTICLES

More in ClinTech

New from BioClinca, a white paper on Strengthening the Management of Clinical Trial Supplies.

This white paper discusses the benefits of predictive technology to forecast the clinical supply needs of a clinical trial. It explores how sponsors can also gain insight and efficiencies by incorporating clinical supply management teams early in the process for more effective trial design, more realistic assessment of funding needs, and more productive processes throughout the life of the trial.

You can view and download the white paper here.

Below, you can also find a series of podcasts that Editor-in-Chief, Lisa Henderson, had in conversation with Victoria Dunay, Manager of the Clinical Supply Chain, Chain Optimization at BioClinica, and Nicole Garmon, Product Manager at BioClinica.

In them they discuss the trends in Clinical Trials Supply Management. Check out the podcasts below.

Related to this article

View more
© C Davids/peopleimages.com - © C Davids/peopleimages.com - stock.adobe.com
What "Patient Voice" Actually Requires: Beyond the Buzzword
The clinical research industry talks about patient-centeredness constantly but embeds it too late, too narrowly, and without clear ownership, and the cost shows up in enrollment failures, protocol deviations, and outcomes that don't reflect what patients actually care about.
Read more
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
This episode of The Human Side of Clinical Trials, hosted by Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., explores why training completion metrics like attendance and quiz scores fail to capture true study readiness, and how measuring both competence and confidence can reveal trial risks before enrollment even begins.
Read more